STOCK TITAN

[Form 4] Dolby Laboratories, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Dolby Laboratories (DLB) reported insider activity by President & CEO and Director Kevin Yeaman. On 10/14/2025, he exercised an employee stock option for 25,000 Class A shares at $45.5 per share (code M), then sold 11,214 shares at a weighted average price of $68.5057 and 13,786 shares at a weighted average price of $69.173 (both code S), all held indirectly by a family trust. Following the reported transactions, 114,725 shares were beneficially owned indirectly by the trust. Holdings also include 127,735 RSUs that are subject to vesting.

Dolby Laboratories (DLB) ha riportato attività di insider da parte del presidente e amministratore delegato e direttore Kevin Yeaman. Il 14/10/2025 ha esercitato un opzione azionaria per dipendenti per 25.000 azioni Class A a 45,50 dollari per azione (codice M), poi ha venduto 11.214 azioni a un prezzo medio ponderato di 68,5057 dollari e 13.786 azioni a un prezzo medio ponderato di 69,173 dollari (entrambi codice S), tutte detenute indirettamente da una trust familiare. A seguito delle transazioni riportate, 114.725 azioni erano possedute beneficiariamente indirettamente dal trust. Le partecipazioni includono anche 127.735 RSU soggette a vesting.

Dolby Laboratories (DLB) informó sobre actividad de insider por parte del presidente y director Kevin Yeaman. El 14/10/2025, ejerció una opción de compra de acciones para empleados sobre 25.000 acciones Clase A a 45,50 $ por acción (código M), luego vendió 11.214 acciones a un precio medio ponderado de 68,5057 $ y 13.786 acciones a un precio medio ponderado de 69,173 $ (ambos código S), todas ellas poseídas indirectamente por un fideicomiso familiar. Tras las transacciones reportadas, el fideicomiso poseía indirectamente 114.725 acciones. Las participaciones también incluyen 127.735 RSU sujetas a vesting.

Dolby Laboratories (DLB)가 Kevin Yeaman 사장 겸 최고경영자 겸 이사에 의한 내부자 거래를 보고했습니다. 2025년 10월 14일, 그는 직원 주식 옵션으로 Class A 주식 25,000주를 주당 45.50달러에 행사했고(코드 M), 이후 11,214주를 가중평균가 68.5057달러에, 13,786주를 가중평균가 69.173달러에 판매했습니다(두 거래 모두 코드 S). 모두 가족신탁을 통해 간접 보유되었습니다. 보고된 거래 이후 신탁은 간접적으로 114,725주를 보유했습니다. 보유에는 vesting 대상인 127,735주의 RSU도 포함됩니다.

Dolby Laboratories (DLB) a signalé une activité d'initié de la part du président-directeur général et administrateur Kevin Yeaman. Le 14/10/2025, il a exercé une option d'achat d'actions pour employés sur 25 000 actions de classe A à 45,50 $ par action (code M), puis a vendu 11 214 actions à un prix moyen pondéré de 68,5057 $ et 13 786 actions à 69,173 $ (tous deux code S), le tout détenu indirectement par une fiducie familiale. Suite aux transactions rapportées, 114 725 actions étaient détenues de manière bénéficiaire indirectement par la fiducie. Les avoirs comprennent également 127 735 RSU soumis à vesting.

Dolby Laboratories (DLB) meldete Insider-Tätigkeiten des Präsidenten, CEO und Direktors Kevin Yeaman. Am 14.10.2025 übte er eine Mitarbeiteraktienoption für 25.000 Class-A-Aktien zum Preis von 45,50 USD je Aktie (Code M) aus, kaufte danach 11.214 Aktien zu einem gewichteten Durchschnittspreis von 68,5057 USD und 13.786 Aktien zu 69,173 USD (beide Code S); alle wurden indirekt von einem Familientrust gehalten. Nach den gemeldeten Transaktionen besaß der Trust indirekt 114.725 Aktien. Die Beteiligungen umfassen außerdem 127.735 RSUs, die vesten sollen.

Dolby Laboratories (DLB) أبلغت عن نشاط داخلي من قبل الرئيس التنفيذي والمدير Kevin Yeaman. في 14/10/2025، قام بممارسة خيار أسهم موظفين لـ25,000 سهم من فئة A بسعر 45.5 دولار للسهم (رمز M)، ثم باع 11,214 سهماً بسعر متوسط وزني 68.5057 دولار و13,786 سهماً بسعر متوسط وزني 69.173 دولار (كلاهما رمز S)، جميعها مملوكة بشكل غير مباشر من خلال صندوق عائلي. بعد الصفقات المعلنة، كانت 114,725 سهماً مملوكة بشكل غير مباشر من قبل الصندوق. تشمل الحيازة أيضاً 127,735 RSU قيد الاستحقاق.

Dolby Laboratories (DLB) 报告了由董事长兼首席执行官及董事 Kevin Yeaman 进行的内部人交易。2025年10月14日,他以每股45.5美元的价格行使员工股票期权购入25,000股A类股票(代码M),随后以加权平均价格68.5057美元出售11,214股,及以加权平均价格69.173美元出售13,786股(两笔交易均为代码S),均通过一个家族信托间接持有。交易后,该信托间接拥有114,725股。持股还包括127,735份仍在归属中的RSU。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Dolby Laboratories (DLB) ha riportato attività di insider da parte del presidente e amministratore delegato e direttore Kevin Yeaman. Il 14/10/2025 ha esercitato un opzione azionaria per dipendenti per 25.000 azioni Class A a 45,50 dollari per azione (codice M), poi ha venduto 11.214 azioni a un prezzo medio ponderato di 68,5057 dollari e 13.786 azioni a un prezzo medio ponderato di 69,173 dollari (entrambi codice S), tutte detenute indirettamente da una trust familiare. A seguito delle transazioni riportate, 114.725 azioni erano possedute beneficiariamente indirettamente dal trust. Le partecipazioni includono anche 127.735 RSU soggette a vesting.

Dolby Laboratories (DLB) informó sobre actividad de insider por parte del presidente y director Kevin Yeaman. El 14/10/2025, ejerció una opción de compra de acciones para empleados sobre 25.000 acciones Clase A a 45,50 $ por acción (código M), luego vendió 11.214 acciones a un precio medio ponderado de 68,5057 $ y 13.786 acciones a un precio medio ponderado de 69,173 $ (ambos código S), todas ellas poseídas indirectamente por un fideicomiso familiar. Tras las transacciones reportadas, el fideicomiso poseía indirectamente 114.725 acciones. Las participaciones también incluyen 127.735 RSU sujetas a vesting.

Dolby Laboratories (DLB)가 Kevin Yeaman 사장 겸 최고경영자 겸 이사에 의한 내부자 거래를 보고했습니다. 2025년 10월 14일, 그는 직원 주식 옵션으로 Class A 주식 25,000주를 주당 45.50달러에 행사했고(코드 M), 이후 11,214주를 가중평균가 68.5057달러에, 13,786주를 가중평균가 69.173달러에 판매했습니다(두 거래 모두 코드 S). 모두 가족신탁을 통해 간접 보유되었습니다. 보고된 거래 이후 신탁은 간접적으로 114,725주를 보유했습니다. 보유에는 vesting 대상인 127,735주의 RSU도 포함됩니다.

Dolby Laboratories (DLB) a signalé une activité d'initié de la part du président-directeur général et administrateur Kevin Yeaman. Le 14/10/2025, il a exercé une option d'achat d'actions pour employés sur 25 000 actions de classe A à 45,50 $ par action (code M), puis a vendu 11 214 actions à un prix moyen pondéré de 68,5057 $ et 13 786 actions à 69,173 $ (tous deux code S), le tout détenu indirectement par une fiducie familiale. Suite aux transactions rapportées, 114 725 actions étaient détenues de manière bénéficiaire indirectement par la fiducie. Les avoirs comprennent également 127 735 RSU soumis à vesting.

Dolby Laboratories (DLB) meldete Insider-Tätigkeiten des Präsidenten, CEO und Direktors Kevin Yeaman. Am 14.10.2025 übte er eine Mitarbeiteraktienoption für 25.000 Class-A-Aktien zum Preis von 45,50 USD je Aktie (Code M) aus, kaufte danach 11.214 Aktien zu einem gewichteten Durchschnittspreis von 68,5057 USD und 13.786 Aktien zu 69,173 USD (beide Code S); alle wurden indirekt von einem Familientrust gehalten. Nach den gemeldeten Transaktionen besaß der Trust indirekt 114.725 Aktien. Die Beteiligungen umfassen außerdem 127.735 RSUs, die vesten sollen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YEAMAN KEVIN J

(Last) (First) (Middle)
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET

(Street)
SAN FRANCISCO CA 94103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/14/2025 M 25,000 A $45.5 139,725 I By a trust(1)
Class A Common Stock 10/14/2025 S 11,214 D $68.5057(2) 128,511 I By a trust(1)
Class A Common Stock 10/14/2025 S 13,786 D $69.173(3) 114,725 I By a trust(1)
Class A Common Stock 127,735(4) D
Class A Common Stock 2.5592 I By a son
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $45.5 10/14/2025 M 25,000 (5) 12/15/2026 Class A Common Stock 25,000 $0 35,615 I By a trust(1)
Explanation of Responses:
1. By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
2. The shares were sold in multiple transactions at prices ranging from $67.83 to $68.81, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
3. The shares were sold in multiple transactions at prices ranging from $68.89 to $69.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
4. Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
5. This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman 10/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DLB’s CEO transact on 10/14/2025?

He exercised an option for 25,000 shares at $45.5 and sold 11,214 and 13,786 shares at weighted average prices of $68.5057 and $69.173.

How many DLB shares does the trust hold after the transactions?

Following the transactions, 114,725 shares were beneficially owned indirectly by the family trust.

What were the sale price ranges disclosed for DLB shares?

Sales occurred in multiple transactions with ranges of $67.83–$68.81 and $68.89–$69.35; weighted averages reported.

What was the exercise price of the DLB stock option?

The option was exercised at $45.5 per share for 25,000 underlying Class A shares.

Does the CEO have additional equity awards at DLB?

Holdings include 127,735 shares underlying restricted stock units that are subject to forfeiture until they vest.

In what capacity does Kevin Yeaman serve at DLB?

He is a Director and serves as President and CEO.
Dolby Laboratories Inc

NYSE:DLB

DLB Rankings

DLB Latest News

DLB Latest SEC Filings

DLB Stock Data

6.59B
60.32M
1.35%
98.06%
1.9%
Specialty Business Services
Patent Owners & Lessors
Link
United States
SAN FRANCISCO